Daily Dose - Dec 23rd, 2024
Daily Dose |
View online
December 23, 2024
Cell and gene therapy manufacturing challenges to persist in 2025
As potentially curative therapies, CGTs offer hope to millions of patients but remain complex and difficult to manufacture at scale.
Read More
FDA hits Viatris with warning letter, restricts US imports for violations at India plant
The regulator took the actions following an inspection earlier this year at the company’s oral finished dose manufacturing facility in Indore, India.
Read More
Lonza expands capsule manufacturing capacity in China, India amid restructuring plans
The expansion comes on the heels of Lonza’s announcement earlier this month that it is getting rid of its Capsules & Health Ingredients division.
Read More